/
DEAL NEWS: WIPIT advises shareholders of Sonormed on exit to InfectoPharm
InfectoPharm Arzneimittel und Consilium GmbH acquires Sonormed GmbH, a pioneer in digital health applications.

InfectoPharm Arzneimittel und Consilium GmbH, a family-owned company specializing in the new and further development of pharmaceuticals, has acquired all shares in Sonormed GmbH. Sonormed, known as the developer of the first app on prescription, is a pioneer in the field of digital health applications (DigAs).

Our Berlin partner Prof. Dr. Hans-Eric Rasmussen-Bonne, LL.M. advises on the transaction on behalf of the founders, VC investors and business angels.

Further information in the press release of High-Tech Gründerfonds.